New research solves riddle of allergic reactionsFebruary 2nd, 2009 - 1:09 pm ICT by IANS
London, Feb 2 (IANS) A new research has solved the riddle of allergic reactions and how they may even become fatal, potentially opening the way for new allergy drugs. A study by scientists from Queen’s University of Belfast, University of Oxford and Trinity College, Dublin, shows how eotaxin, a chemical that helps immune cells locate the site of infection, blocks basic “fighter” cells from transforming into “seeker” dendritic cells, resulting in a heightened allergic response.
“Our study reveals a new role for the chemokine eotaxin in controlling immune cell types at the site of allergic reaction,” said Nigel Stevenson, a researcher. “These findings are crucial for our understanding of allergic responses and may be instrumental for the design of new allergy drugs.”
More than 50 million Americans suffer from allergies each year, the sixth leading cause of chronic illness in the country, costing more than $18 billion. The most severe type of allergic reaction is called “anaphylaxis”, which can be fatal, according to US Center for Disease Control.
Stevenson and colleagues made this discovery by using immune cells grown in the lab and from healthy volunteers. Then the researchers mimicked what occurs during an allergic reaction by treating the cells with eotaxin, which was previously believed to only attract immune cells during an allergic reaction.
Through a series of lab procedures, they tracked changes in immune cell type and found that eotaxin inhibits monocytes becoming dendritic cells (that find foreign invaders so other immune cells can neutralise them), resulting in more “fighter” cells being present during an allergic response, said an Oxford release.
This discovery shows how and why eotaxin plays an important role in the severity of allergic reactions and may be a target for an entirely new class of allergy medications.
These results were published in the February issue of the Journal of Leukocyte Biology.
- Novel drug target for severe allergic reactions identified - Jan 30, 2009
- Discovery could prevent deaths from severe flu outbreaks - Mar 01, 2012
- Possible treatment for peanut allergy identified - Dec 10, 2010
- Tick bite turns red meat into nasty allergy - Jul 25, 2012
- Cell component that triggers cat allergy identified - Mar 10, 2011
- Breakthrough may pave way for new malaria drugs - Nov 27, 2011
- How reovirus kills cancer cells - Feb 21, 2011
- Loneliness 'ups risk of inflammatory diseases' - Feb 09, 2011
- Scientists figure out why foetus is not rejected - Jun 10, 2012
- Scientists find new origin for a critical immune response - Mar 02, 2009
- Clues to how bacteria and viruses are identified as enemies revealed - Oct 01, 2010
- Way to turn off immune system's allergic reaction discovered - Oct 02, 2010
- Cancer drug may help treat arthritis, multiple sclerosis - Jul 01, 2010
- Discovery could lead to 'next-gen' vaccines - Apr 08, 2012
- Molecular switch that triggers allergic response in humans identified - Jan 21, 2010
Tags: allergic reaction, allergic reactions, allergic response, allergic responses, allergy drugs, allergy medications, anaphylaxis, belfast university, center for disease control, chronic illness, fighter cells, immune cell, immune cells, journal of leukocyte biology, london feb, s university, target, trinity college dublin, university of belfast, university of oxford